These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 4359182

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis.
    Bielawiec M, Myśliwiec M, Perzanowski A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):483-8. PubMed ID: 4139068
    [No Abstract] [Full Text] [Related]

  • 3. Prophylaxis of recurrent venous thrombosis with long-term enhancement of fibrinolysis.
    Bielawiec M, Lukjan H, Myśliwiec M, Dabrowski S.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):971-6. PubMed ID: 94894
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chylomicron and very low-density lipoprotein apolipoprotein B metabolism: mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia.
    Hazzard WR, Kushwaha RS, Applebaum-Bowden D, Haffner SM, Steinmetz A, Foster DM.
    Metabolism; 1984 Oct; 33(10):873-81. PubMed ID: 6482732
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Altering lipid patterns in adult males.
    Appelbaum JJ, Amundsen MA, Perkin DK.
    J Occup Med; 1974 Aug; 16(8):539-42. PubMed ID: 4367267
    [No Abstract] [Full Text] [Related]

  • 8. Idiopathic recurrent superficial thrombophlebitis: treatment with fibrinolytic enhancement.
    Jarrett PE, Morland M, Browse NL.
    Br Med J; 1977 Apr 09; 1(6066):933-4. PubMed ID: 856391
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The effect of a combination treatment with clofibrate on the lipoprotein pattern of endogenous hypertriglyceridemia].
    Vogelberg KH, Althoff B, Heggen EM, Thesseling W.
    Verh Dtsch Ges Inn Med; 1976 Apr 09; 82 Pt 1():832-5. PubMed ID: 196437
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Classification of lipoproteins and lipoprotein disorders.
    Lewis B.
    J Clin Pathol Suppl (Assoc Clin Pathol); 1973 Apr 09; 5():26-31. PubMed ID: 4354845
    [No Abstract] [Full Text] [Related]

  • 17. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A.
    Postgrad Med J; 1975 Apr 09; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Drug therapy of hyperlipidemias].
    Wolfram G.
    Wien Med Wochenschr; 1981 Apr 09; 131(13-14):333-8. PubMed ID: 7281700
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.